Nir Nimrodi
Director/Board Member bei EVOGENE LTD.
Vermögen: - $ am 31.03.2024
Profil
Nir Nimrodi is currently the Chairman & Chief Executive Officer at Accellix, Inc., an Independent Director at Odysight.ai, Inc., and a Director at Evogene Ltd.
Previously, he served as the Chief Executive Officer at Proneuron Biotechnologies, Inc. from 2002 to 2006, and at Mindsense Biosystems Ltd.
from 1999 to 2002.
He also held positions as the Chief Executive Officer & Director at Thermo Fisher Scientific Life Technologies Israel Invt I Ltd., Director-Finance at Teva Pharmaceutical Industries Ltd., and Vice President & General Manager at Life Technologies, Inc. From 2014 to 2019, he worked as the Chief Business Officer at Precigen, Inc. Mr. Nimrodi obtained his undergraduate degree and MBA from Tel-Aviv University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EVOGENE LTD
-.--% | 17.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Nir Nimrodi
| Unternehmen | Position | Beginn |
|---|---|---|
| EVOGENE LTD. | Director/Board Member | 01.09.2022 |
| ODYSIGHT.AI INC. | Director/Board Member | 13.08.2023 |
Accellix, Inc.
 Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | Chief Executive Officer | 15.01.2020 |
Ehemalige bekannte Positionen von Nir Nimrodi
| Unternehmen | Position | Ende |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | 05.04.2019 |
Proneuron Biotechnologies, Inc.
 Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | Chief Executive Officer | 01.12.2006 |
| Mindsense Biosystems Ltd. | Chief Executive Officer | 01.02.2002 |
Thermo Fisher Scientific Life Technologies Israel Invt I Ltd.
 Thermo Fisher Scientific Life Technologies Israel Invt I Ltd. Financial ConglomeratesFinance Part of Thermo Fisher Scientific, Inc., Thermo Fisher Scientific Life Technologies Israel Invt I Ltd. operates as a British non-trading company. The private company is based in Cheshire, UK. | Chief Executive Officer | - |
Life Technologies, Inc.
 Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Corporate Officer/Principal | - |
Ausbildung von Nir Nimrodi
| Tel-Aviv University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| PRECIGEN, INC. | Health Technology |
| ODYSIGHT.AI INC. | Consumer Durables |
| EVOGENE LTD. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Life Technologies, Inc.
Life Technologies, Inc. BiotechnologyHealth Technology Life Technologies, Inc. provides essential technologies needed by the biotechnology and biopharmaceutical communities. The company manufactures and markets a breadth of offerings unique in the industry, used in applications of the life sciences discovery, development, and production process | Health Technology |
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | Health Technology |
Proneuron Biotechnologies, Inc.
Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | Health Technology |
| Mindsense Biosystems Ltd. | |
Thermo Fisher Scientific Life Technologies Israel Invt I Ltd.
Thermo Fisher Scientific Life Technologies Israel Invt I Ltd. Financial ConglomeratesFinance Part of Thermo Fisher Scientific, Inc., Thermo Fisher Scientific Life Technologies Israel Invt I Ltd. operates as a British non-trading company. The private company is based in Cheshire, UK. | Finance |
